VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $156,000 | -3.7% | 14,289 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $162,000 | -33.6% | 14,289 | -8.1% | 0.01% | -22.2% |
| Q4 2021 | $244,000 | -34.6% | 15,553 | -28.5% | 0.01% | -25.0% |
| Q3 2021 | $373,000 | -64.4% | 21,754 | -55.3% | 0.01% | -52.0% |
| Q2 2021 | $1,047,000 | +43.2% | 48,669 | 0.0% | 0.02% | +38.9% |
| Q1 2021 | $731,000 | -5.2% | 48,669 | -17.0% | 0.02% | +12.5% |
| Q4 2020 | $771,000 | +88.5% | 58,651 | +135.6% | 0.02% | +77.8% |
| Q4 2019 | $409,000 | +23.6% | 24,896 | 0.0% | 0.01% | +12.5% |
| Q3 2019 | $331,000 | -36.1% | 24,896 | -11.6% | 0.01% | -33.3% |
| Q1 2019 | $518,000 | -56.1% | 28,171 | -37.6% | 0.01% | -58.6% |
| Q4 2018 | $1,180,000 | +13.8% | 45,167 | 0.0% | 0.03% | +26.1% |
| Q3 2018 | $1,037,000 | +20.6% | 45,167 | 0.0% | 0.02% | +15.0% |
| Q2 2018 | $860,000 | +13.0% | 45,167 | 0.0% | 0.02% | +11.1% |
| Q1 2018 | $761,000 | -32.2% | 45,167 | -38.9% | 0.02% | -30.8% |
| Q4 2017 | $1,123,000 | -15.1% | 73,870 | 0.0% | 0.03% | -13.3% |
| Q3 2017 | $1,322,000 | – | 73,870 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |